ZBTB7A enhances metastasis in various cancers, including colorectal cancer, breast cancer and nasopharyngeal carcinoma by facilitating epithelial-mesenchymal transition, immune modulation, and altering glycolysis [32–36]. Here, ZBTB7A is linked to breast carcinoma.